Enzyre is a developer of diagnostic technology.
Enzyre has raised €13M across 2 funding rounds from 7 investors, most recently a Series A round in Nov 2022. Based in Nijmegen, Netherlands; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-11-02 | Series A | €12M | Demcon Investment,Dutch Government,i&i Biotech Fund,Novalis Biotech,Oost NL,Takeda Ventures | View deal → |
| 2020-07-27 | Other | €1.4M | Novalis Biotechnology Incubation | View deal → |
